Waltham, Massachusetts-based Revvity, Inc. (RVTY) is a global life sciences and diagnostics company specializing in ...

Revvity (RVTY) announced that the Massachusetts Superior Court has ruled in its favor and will issue a permanent injunction to enforce ...

Bretton Capital Management, an investment management company, released “Bretton Fund” fourth quarter 2024 investor letter. A ...

Chevy Chase Trust Holdings LLC trimmed its holdings in shares of Revvity, Inc. (NYSE:RVTY – Free Report) by 3.4% during the ...

Shares of Revvity Inc. RVTY slipped 2.62% to $119.16 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to 6,083.57 and ...

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Guardant Health (GH – Research Report) today and set a price target of $53.00.

Revvity (NYSE:RVTY – Get Free Report) had its price target upped by Barclays from $135.00 to $140.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage ...

WALTHAM, Mass., January 23, 2025--The Board of Directors of Revvity (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on May 9 ...

Shares of Revvity Inc. RVTY shed 1.20% to $111.27 Wednesday, on what proved to be an all-around grim trading session for the ...